SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000320017-16-000092
Filing Date
2016-03-14
Accepted
2016-03-14 07:20:21
Documents
1
Period of Report
2016-03-14
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments

Document Format Files

Seq Description Document Type Size
1 8-K/A a8ka031416.htm 8-K/A 23865
  Complete submission text file 0000320017-16-000092.txt   25306
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33650 | Film No.: 161502395
SIC: 8090 Services-Misc Health & Allied Services, NEC